# US 2015/0148523 A1 · Gamma amino acid building blocks

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148523 A1
- Document ID: US20150148523A1
- Status: Published application
- Kind: A1
- Application number: 14/166,007
- Filed: 2014-01-28
- Published: 2015-05-28
- Earliest claimed: 2009-10-14
- Assignees: Wisconsin Alumni Research Foundation
- Applicants: Wisconsin Alumni Research Foundation
- Inventors: Samuel Helmer Gellman; Li Guo; Michael Giuliano
- Web page: https://patentgrep.com/patent/US20150148523A1

## CPC

- C07C 205/44: the carbon skeleton being further substituted by —CHO groups
- C07C 201/12: by reactions not involving the formation of nitro groups
- C07C 205/55: having nitro groups or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
- C07C 233/48: having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
- C07C 237/24: having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C 269/00: Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups [IMAGE cpc-sch-C07C-0964.gif], the nitrogen atom not being part of nitro or nitroso groups
- C07C 271/24: with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C 271/66: Y being a hetero atom
- C07D 211/56: Nitrogen atoms (nitro radicals C07D211/38)
- C07D 211/60: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07K 5/0205: {containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}
- C07K 5/06078: {and aromatic or cycloaliphatic}
- C07K 5/1016: {and aromatic or cycloaliphatic}
- C07K 7/06: having 5 to 11 amino acids
- C07C 2601/08: the ring being saturated
- C07C 2601/14: The ring being saturated
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The invention provides compounds and methods, for example, to carry out organocatalytic Michael additions of aldehydes to cyclically constrained nitroethylene compounds catalyzed by a proline derivative to provide cyclically constrained α-substituted-γ-nitro-aldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96 to >99% e.e.). The Michael adducts can bear a single substituent or dual substituents adjacent to the carbonyl. The Michael adducts can be efficiently converted to cyclically constrained protected γ-amino acid residues, which are essential for systematic conformational studies of γ-peptide foldamers. New methods are also provided to prepare other γ-amino acids and peptides. These new building blocks can be used to prepare foldamers, such as α/γ-peptide foldamers, that adopt specific helical conformations in solution and in the solid state.

## Claims

### Claim 1

A compound of Formula I:
wherein
R1 is hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle;
R2 is H, OH, an amino acid or peptide, or ORx wherein Rx is alkyl, cycloalkyl, aryl, heteroaryl, heterocycle, or an oxygen protecting group;
Y is nitro, amino, —NHRy, or —N(Ry)2 wherein each Ry is independently alkyl, cycloalkyl, aryl, heteroaryl, heterocycle, a nitrogen protecting group, or a nitrogen bonded to an amino acid;
Z is O, S, or H, and the dashed line to Z is an optionally present bond that is absent when Z is H;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon, or nitrogen provided A6 is not a direct bond;
A6 is carbon or a direct bond;
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or when nitrogen, one nitrogen protecting group; and
wherein each alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of any R1, R2, Rx, or Ry is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
or a salt or solvate thereof.

### Claim 2 (depends on 1)

The compound of claim 1 wherein the compound is a compound of Formula IA:
wherein
R1 is hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R1 is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
R2 is H, OH, an amino acid or peptide, or ORx wherein Rx is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of Rx is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon, or nitrogen provided A6 is not a direct bond;
A6 is carbon or a direct bond; and
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or when nitrogen, one nitrogen protecting group;
or a salt or solvate thereof.

### Claim 3 (depends on 1)

The compound of claim 1 wherein the compound is a compound of Formula II:
wherein
R1 is hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R1 is optionally substituted with one to five alkyl, alkoxy, fluoro, hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
Y is nitro, amino, protected amino, or a nitrogen bonded to an amino acid;
R3 is an amino acid side chain;
P is hydrogen, a carboxylic acid protecting group, or —OP is an amino acid residue or peptide;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon or nitrogen;
A6 is carbon or a direct bond; and
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, fluoro, hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or one nitrogen protecting group;
or a salt or solvate thereof.

### Claim 4 (depends on 3)

The compound of claim 3 wherein R1 is H or alkyl, A3-A6 are each carbon, R3 is H or alkyl, P is H, methyl or acetyl, and Y is nitro or protected amino.

### Claim 5 (depends on 1)

A method for preparing a compound of claim 1 wherein R2 is H comprising:
contacting a cyclic compound of 5 or 6 ring atoms that includes a nitroethylene moiety within the ring and that optionally includes one or two nitrogen atoms in the ring, wherein the carbon atoms in the ring are optionally substituted and the optional nitrogen atom or atoms in the ring are optionally substituted by a nitrogen protecting group; and
an aldehyde that has at least one α-hydrogen;
in the presence of an organic solvent, and a proline derivative, for a period of time sufficient to provide the compound of claim 1.

### Claim 6 (depends on 5)

The method of claim 5 wherein the aldehyde has an α-methylene group or an α-methine group.

### Claim 7 (depends on 1, 5)

The method of claim 5 wherein the contacting is carried out in the presence of a carboxylic acid, the proline derivative is a chiral pyrrolidine catalyst, and the compound of claim 1 is prepared in at least about 80% enantiomeric purity.

### Claim 8 (depends on 1, 5)

The method of claims 5 further comprising reducing an aldehyde moiety of the compound of claim 1 to an alcohol, oxidizing the resulting alcohol to a carboxylic acid, reducing the nitro moiety of the compound of claim 1 to an amine, or a combination thereof.

### Claim 9

A method for preparing a compound of Formula III:
wherein
R1 is hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R1 is optionally substituted with one to five alkyl, alkoxy, fluoro, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon, or nitrogen provided that A6 is not a direct bond;
A6 is carbon, or a direct bond; and
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, halo, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or one nitrogen protecting group; or a salt or solvate thereof;
comprising contacting:
a compound of Formula IV:
wherein R1 is as defined for Formula III; and
a cyclic compound of 5 or 6 ring atoms that includes a nitroethylene moiety within the ring and that optionally includes one or two nitrogen atoms in the ring, wherein the carbon atoms in the ring are optionally substituted and the optional nitrogen atom or atoms in the ring are optionally substituted by a nitrogen protecting group;
in the presence of an organic solvent and a proline derivative, for a period of time sufficient to provide the compound of Formula III.

### Claim 10

A compound of Formula V:
wherein
Y is NO2 or NH2;
R is H or OH;
R1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R1 is optionally substituted with one to five alkyl, alkoxy, fluoro, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon, or nitrogen provided that A6 is not a direct bond;
A6 is carbon, or a direct bond; and
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, halo, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or one nitrogen protecting group;
or a salt or solvate thereof.

### Claim 11

A method of preparing a compound of Formula VI:
wherein
R1 is hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R1 is optionally substituted with one to five alkyl, alkoxy, fluoro, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon, or nitrogen provided that A6 is not a direct bond;
A6 is carbon, or a direct bond; and
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, halo, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or one nitrogen protecting group;
comprising contacting:
a compound of Formula VII:
wherein A3-A6 are as defined for Formula VI; and
a compound of Formula VIII:
wherein R1 is as defined for Formula VI;
in the presence of an organic solvent and a proline derivative, for a period of time sufficient to provide the compound of Formula VI, or a salt thereof.

### Claim 12 (depends on 11)

The method of claim 11 wherein the contacting is carried out in the presence of a carboxylic acid, the proline derivative is a chiral pyrrolidine catalyst, and the compound of Formula VI is prepared in an enantiomerically enriched form.

### Claim 13

A peptide comprising a γ-amino acid residue, wherein at least one γ-amino acid residues is a residue of Formula IX:
wherein
A is H, a nitrogen protecting group, an amino acid, or a chain of two or more amino acids;
B is H, a carboxylic acid protecting group, an amino acid, or a chain of two or more amino acids;
R1 is hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon, or nitrogen provided A6 is not a direct bond;
A6 is carbon or a direct bond; and
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or when nitrogen, one nitrogen protecting group; and
wherein each alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups; and
or at least one residue is a residue of Formula X:
wherein
A is H, a nitrogen protecting group, an amino acid, or a chain of two or more amino acids;
B is H, a carboxylic acid protecting group, an amino acid, or a peptide;
R1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle, or hydrogen provided that the peptide comprises a residue of Formula IX; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R1 is optionally substituted with one to five alkyl, alkoxy, fluoro, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;
A3 is carbon;
A4 is carbon or nitrogen;
A5 is carbon, or nitrogen provided that A6 is not a direct bond;
A6 is carbon, or a direct bond; and
each of A3-A6 are optionally substituted with one or two alkyl, alkoxy, halo, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or one nitrogen protecting group.

### Claim 14 (depends on 13)

The peptide of claim 13 wherein the peptide comprises three or more residues and the peptide forms a 12-helix, a 13-helix, or a 14-helix.

### Claim 15 (depends on 14)

The peptide of claim 14 wherein the peptide comprises alternating α- and γ-amino acid residues and the peptide forms a 12-helix.

### Claim 16 (depends on 14)

The peptide of claim 14 wherein the peptide comprises one or more γαα peptide sequences and the peptide forms a 12-helix.

### Claim 17 (depends on 14)

The peptide of claim 14 wherein the peptide comprises alternating β- and γ-amino acid residues and the peptide forms a 13-helix.

### Claim 18 (depends on 14)

The peptide of claim 14 wherein the peptide comprises three or more γ-amino acid residues and the peptide forms a 14-helix.
